PathGroup Expands Proscia Partnership for Cancer Diagnostics
PathGroup will advance its standard of diagnosis for diseases like cancer through Proscia’s Concentriq Dx digital pathology software platform.
Read MorePosted by Andy Lundin | Mar 1, 2023 | Cancer, Digital Pathology |
PathGroup will advance its standard of diagnosis for diseases like cancer through Proscia’s Concentriq Dx digital pathology software platform.
Read MorePosted by Andy Lundin | Feb 28, 2023 | Molecular Diagnostic Analyzers |
Experts have developed a new methodology to detect RNA viruses based on the triplex-forming probe technology.
Read MorePosted by Andy Lundin | Feb 28, 2023 | Covid 19 |
The new COVID testing method can potentially catch infections a matter of hours after exposure with near-perfect accuracy.
Read MorePosted by Andy Lundin | Feb 24, 2023 | Covid 19 |
The U.S. FDA issued an emergency use authorization for the first over-the-counter at-home test that can differentiate influenza and COVID.
Read MorePosted by Andy Lundin | Feb 23, 2023 | Cancer |
Millions of people in the U.S. continued to miss critical cancer screening tests during the second year of the COVID pandemic.
Read More